| Literature DB >> 31963485 |
Xiangsheng Zhao1, Shihui Zhang1, Dan Liu2, Meihua Yang1,3, Jianhe Wei1,3.
Abstract
Dalbergia odorifera, a traditional Chinese medicine, has been used to treat cardio- and cerebrovascular diseases in China for thousands of years. Flavonoids are major active compounds in D. odorifera. In this paper, a rapid and sensitive ultra-high performance liquid chromatography-triple quadrupole mass spectrometry method was developed and validated for simultaneous determination of 17 flavonoids in D. odorifera. Quantification was performed by multiple reaction monitoring using electrospray ionization in negative ion mode. Under the optimum conditions, calibration curves for the 17 analytes displayed good linearity (r2 > 0.9980). The intra- and inter-day precisions (relative standard deviations) were lower than 5.0%. The limit of quantitation ranged from 0.256 to 18.840 ng/mL. The mean recovery range at three spiked concentrations was 94.18-101.97%. The validated approach was successfully applied to 18 samples of D. odorifera. Large variation was observed for the contents of the 17 analytes. Sativanone and 3'-O-methylviolanone were the dominant compounds. The fragmentation behaviors of six flavonoids were investigated using UPLC with quadrupole time-of-flight tandem mass spectrometry. In negative ion electrospray ionization mass spectrometry, all the flavonoids yielded prominent [M - H]- ions. Fragments for losses of CH3, CO, and CO2 were observed in the mass spectra. Formononetin, liquiritigenin, isoliquiritigenin, sativanone, and alpinetin underwent retro-Diels-Alder fragmentations. The proposed method will be helpful for quality control of D. odorifera.Entities:
Keywords: Dalbergia odorifera; UPLC-MS/MS; assay; flavonoid; fragmentation behavior
Year: 2020 PMID: 31963485 PMCID: PMC7024225 DOI: 10.3390/molecules25020389
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of the seventeen target compounds. 1, 3′-Hydroxydaidein; 2, Butein; 3, Daidzein; 4, Liquiritigenin; 5, Eriodictyol; 6, Butin; 7, Naringenin; 8, Genistein; 9, Tectorigenin; 10, Alpinetin; 11, Isoliquiritigenin; 12, Formononetin; 13, Dalbergin; 14, 3′-O-methylviolanone; 15, Sativanone; 16, Pinocembrin; 17, Prunetin. Analytes numbers in the test is the same as in this figure.
MS/MS parameters for 17 target compounds.
| No. | Compounds | Ion Mode | RT (min) | Precursor Ion | Cone Voltage (V) | Product ion 1 Q | Collision Energy (eV) | Product Ion 2 I | Collision Energy (eV) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3′-Hydroxydaidein | ESI- | 4.97 | 269 | 52 | 213 | 28 | 241 | 24 |
| 2 | Butein | ESI- | 5.12 | 271 | 35 | 135 | 20 | 253 | 17 |
| 3 | Daidzein | ESI- | 5.95 | 253 | 51 | 208 | 31 | 224 | 26 |
| 4 | Liquiritigenin | ESI- | 6.23 | 255 | 40 | 135 | 15 | 119 | 22 |
| 5 | Eriodictyol | ESI- | 6.24 | 287 | 38 | 151 | 17 | 135 | 24 |
| 6 | Butin | ESI- | 7.59 | 271 | 39 | 135 | 31 | 91 | 37 |
| 7 | Naringenin | ESI- | 7.94 | 271 | 40 | 151 | 20 | 119 | 24 |
| 8 | Genistein | ESI- | 8.04 | 269. | 48 | 133 | 32 | 181 | 28 |
| 9 | Tectorigenin | ESI- | 8.30 | 2989 | 40 | 284 | 19 | 240 | 22 |
| 10 | Alpinetin | ESI- | 8.65 | 269 | 44 | 165 | 20 | 227 | 21 |
| 11 | Isoliquiritigenin | ESI- | 9.62 | 255 | 35 | 135 | 15 | 119 | 23 |
| 12 | Formononetin | ESI- | 10.08 | 267 | 45 | 252 | 22 | 223 | 25 |
| 13 | Dalbergin | ESI- | 10.09 | 267 | 38 | 180 | 27 | 252 | 18 |
| 14 | 3′- | ESI- | 10.62 | 329 | 46 | 135 | 38 | 299 | 36 |
| 15 | Sativanone | ESI- | 11.10 | 299 | 46 | 135 | 37 | 269 | 32 |
| 16 | Pinocembrin | ESI- | 12.47 | 255 | 42 | 107 | 25 | 171 | 25 |
| 17 | Prunetin | ESI- | 12.97 | 283 | 45 | 268 | 21 | 239 | 26 |
| 18 | Rutin (IS) | ESI- | 4.05 | 609 | 62 | 300 | 52 | 271 | 50 |
Q: transitions for quantification; I: transitions for identification.
Figure 2Ultra-high performance liquid chromatography (UHPLC)-MS/MS multiple reaction mode chromatograms of mixed standards (upper) and sample (lower, S9).
Figure 3Effects of (A) solvent concentration, (B) solvent volume, and (C) extraction time on the extraction efficiency of target analytes in S9 sample.
Curves, test range, limit of detection (LOD), limit of quantification (LOQ), precision, and repeatability for the seventeen analytes.
| No. | Compounds | Calibration Curves |
| Linear Range | LOQ | LOD | Precision (RSD, %) | Repeatability | |
|---|---|---|---|---|---|---|---|---|---|
| Intra-Day | Inter-Day | (RSD, %, | |||||||
| 1 | 3′-Hydroxydaidein | 0.9991 | 5.40–1350 | 5.400 | 1.600 | 2.43 | 3.23 | 3.45 | |
| 2 | Butein | 0.9993 | 1.41–2820 | 1.410 | 0.470 | 2.49 | 4.85 | 4.53 | |
| 3 | Daidzein | 0.9989 | 3.02–1510 | 3.020 | 1.000 | 1.74 | 3.01 | 2.98 | |
| 4 | Liquiritigenin | 0.9999 | 1.61–3220 | 1.610 | 0.500 | 1.25 | 2.26 | 3.18 | |
| 5 | Eriodictyol | 0.9997 | 1.36–1360 | 1.360 | 0.453 | 2.38 | 2.45 | 2.06 | |
| 6 | Butin | 0.9986 | 1.51–3020 | 1.510 | 0.458 | 1.85 | 3.54 | 2.77 | |
| 7 | Naringenin | 0.9989 | 2.72–1360 | 2.720 | 0.906 | 2.07 | 4.61 | 4.06 | |
| 8 | Genistein | 0.9988 | 3.82–1910 | 3.820 | 1.528 | 0.76 | 3.33 | 2.54 | |
| 9 | Tectorigenin | 0.9987 | 2.44–1220 | 2.440 | 0.813 | 1.96 | 2.40 | 1.95 | |
| 10 | Alpinetin | 0.9996 | 5.36–1340 | 5.360 | 1.790 | 2.85 | 4.94 | 4.76 | |
| 11 | Isoliquiritigenin | 0.9996 | 1.416–1770 | 1.416 | 0.480 | 0.45 | 3.02 | 3.67 | |
| 12 | Formononetin | 0.9993 | 0.516–1290 | 0.516 | 0.172 | 1.78 | 1.90 | 3.32 | |
| 13 | Dalbergin | 0.9991 | 0.256–1280 | 0.256 | 0.085 | 3.51 | 4.85 | 4.61 | |
| 14 | 3′- | 0.9989 | 9.90–2970 | 9.900 | 3.300 | 2.08 | 4.49 | 2.87 | |
| 15 | Sativanone | 0.9991 | 18.84–5652 | 18.840 | 6.080 | 1.24 | 1.26 | 4.73 | |
| 16 | Pinocembrin | 0.9992 | 2.66–1330 | 2.660 | 0.870 | 1.04 | 1.94 | 3.82 | |
| 17 | Prunetin | 0.9989 | 1.12–2240 | 1.120 | 0.374 | 1.91 | 3.34 | 3.61 | |
Contents of 17 analytes in 18 batches of samples (mg/g).
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1 | 0.1004 | 0.0769 | 0.0546 | 0.7228 | <LOQ | 1.7084 | 0.3902 | 0.0396 | 0.9048 | ND | 0.2994 | 1.1047 | 0.0255 | 0.6973 | 5.8806 | 0.1901 | 0.1207 |
| S2 | 0.1052 | 0.3714 | 0.0422 | 0.8499 | 0.0424 | 0.2862 | 0.3362 | 0.0302 | 0.7439 | ND | 0.4019 | 1.0490 | 0.0452 | 1.4732 | 6.5233 | 0.2467 | 0.1119 |
| S3 | 0.0232 | 0.4628 | <LOQ | 0.6125 | 0.3140 | 0.2346 | 0.6570 | 0.0379 | 0.2066 | 0.0436 | 0.2881 | 0.2712 | 0.1724 | 1.8881 | 8.7726 | 0.8209 | 0.1794 |
| S4 | 0.1340 | 0.0865 | 0.1102 | 1.0619 | <LOQ | 0.0400 | 0.3603 | 0.0828 | 0.8650 | 0.0860 | 0.5860 | 1.2523 | 0.0171 | 0.8051 | 9.5705 | 0.2324 | 0.1228 |
| S5 | <LOQ | 0.4860 | <LOQ | 0.1908 | 0.5322 | 0.2570 | 0.8737 | 0.0234 | 0.1184 | 0.0141 | 0.1192 | 0.0667 | 0.0302 | 7.5830 | 18.2890 | 0.2874 | 0.0806 |
| S6 | 0.0281 | 0.9359 | <LOQ | 0.3571 | 0.5365 | 0.5594 | 0.5046 | 0.0226 | 0.1325 | 0.0241 | 0.1852 | 0.3650 | 0.0164 | 3.8599 | 24.1200 | 0.3118 | 0.1195 |
| S7 | <LOQ | 0.4820 | <LOQ | 0.2767 | 0.0364 | 0.2680 | 0.1307 | 0.0068 | 0.0751 | 0.0310 | 0.1744 | 0.1930 | 0.0701 | 1.0216 | 7.2718 | 0.0500 | 0.0147 |
| S8 | 0.0366 | 0.7531 | <LOQ | 0.5434 | 0.0658 | 0.5064 | 0.2038 | 0.0251 | 0.1711 | 0.0665 | 0.3136 | 0.3630 | 0.1084 | 1.4806 | 7.3738 | 0.1676 | 0.0381 |
| S9 | 0.0888 | 0.9047 | 0.0442 | 0.8766 | 0.5470 | 0.5149 | 1.1659 | 0.0688 | 0.2205 | 0.0258 | 0.4645 | 0.7756 | 0.4961 | 2.8056 | 12.6911 | 1.3608 | 0.3284 |
| S10 | 0.0423 | 0.8399 | <LOQ | 0.5717 | 0.4619 | 0.5250 | 0.7914 | 0.0393 | 0.3628 | 0.0239 | 0.3086 | 0.6162 | 0.3954 | 3.5777 | 14.6963 | 1.1722 | 0.2915 |
| S11 | 0.0961 | 0.9512 | 0.0380 | 1.0640 | 0.0907 | 0.6402 | 0.2374 | 0.0079 | 0.2600 | 0.0130 | 0.5423 | 0.7814 | 0.4026 | 1.6566 | 6.7257 | 0.4049 | 0.0701 |
| S12 | 0.0375 | 0.6593 | <LOQ | 1.0338 | 0.7855 | 0.4597 | 1.5180 | 0.0820 | 0.4318 | 0.0226 | 0.6463 | 0.4233 | 0.0024 | 3.3384 | 15.1491 | 1.2503 | 0.4409 |
| S13 | 0.0431 | 1.0001 | <LOQ | 0.8340 | 1.1740 | 0.6573 | 2.4237 | 0.1641 | 0.2210 | 0.0375 | 0.4746 | 0.6412 | 0.1302 | 4.5177 | 23.7313 | 2.1126 | 0.5725 |
| S14 | 0.0625 | 1.9857 | <LOQ | 1.8790 | 0.0830 | 1.6506 | 0.1734 | ND | 0.2656 | 0.0111 | 1.3703 | 1.1935 | 0.4145 | 1.0923 | 8.3085 | 0.1969 | 0.0464 |
| S15 | 0.0621 | 0.9035 | <LOQ | 0.5811 | 0.2317 | 0.4897 | 0.7012 | 0.0414 | 0.2702 | 0.0211 | 0.3043 | 0.6900 | 0.1995 | 2.5788 | 15.1260 | 0.5150 | 0.2174 |
| S16 | 0.0536 | 0.5246 | 0.0399 | 0.4060 | 0.0321 | 0.2395 | 0.1328 | 0.0161 | 0.1031 | 0.0131 | 0.2361 | 0.3781 | 0.1192 | 0.8817 | 6.6720 | 0.1057 | 0.0315 |
| S17 | <LOQ | 0.2551 | 0.0544 | 0.6073 | <LOQ | 0.1680 | 0.3325 | 0.0300 | 0.1935 | 0.0161 | 0.3011 | 0.4070 | 0.0034 | 1.5828 | 21.6877 | 0.3601 | 0.0606 |
| S18 | ND | 0.1246 | ND | 0.1123 | 0.0243 | 0.0460 | 0.1787 | 0.0053 | 0.0580 | 0.0869 | 0.0719 | 0.0731 | 0.0252 | 1.1494 | 8.3910 | 0.1419 | 0.0325 |
Figure 4MS/MS spectra and the proposed fragmentation pathway of formononetin (a), liquiritigenin (b), and isoliquiritigenin (c).
Figure 5MS/MS spectra and the proposed fragmentation pathway of sativanone (a), alpinetin (b), and dalbergin (c).